1. Home
  2. BEAM vs KAR Comparison

BEAM vs KAR Comparison

Compare BEAM & KAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BEAM
    SELLHOLDBUYas of in 21 minutes
  • KAR
    SELLHOLDBUYas of in 21 minutes
  • Stock Information
  • Founded
  • BEAM 2017
  • KAR 2006
  • Country
  • BEAM United States
  • KAR United States
  • Employees
  • BEAM N/A
  • KAR N/A
  • Industry
  • BEAM Biotechnology: Biological Products (No Diagnostic Substances)
  • KAR Retail-Auto Dealers and Gas Stations
  • Sector
  • BEAM Health Care
  • KAR Consumer Discretionary
  • Exchange
  • BEAM Nasdaq
  • KAR Nasdaq
  • Market Cap
  • BEAM 2.3B
  • KAR 2.1B
  • IPO Year
  • BEAM 2020
  • KAR 2009
  • Fundamental
  • Price
  • BEAM $18.79
  • KAR $19.21
  • Analyst Decision
  • BEAM Strong Buy
  • KAR Buy
  • Analyst Count
  • BEAM 11
  • KAR 5
  • Target Price
  • BEAM $50.50
  • KAR $22.20
  • AVG Volume (30 Days)
  • BEAM 2.5M
  • KAR 920.4K
  • Earning Date
  • BEAM 05-06-2025
  • KAR 04-30-2025
  • Dividend Yield
  • BEAM N/A
  • KAR N/A
  • EPS Growth
  • BEAM N/A
  • KAR N/A
  • EPS
  • BEAM N/A
  • KAR 0.45
  • Revenue
  • BEAM $63,518,000.00
  • KAR $1,788,500,000.00
  • Revenue This Year
  • BEAM N/A
  • KAR $1.43
  • Revenue Next Year
  • BEAM $6.32
  • KAR $6.78
  • P/E Ratio
  • BEAM N/A
  • KAR $42.84
  • Revenue Growth
  • BEAM N/A
  • KAR 5.47
  • 52 Week Low
  • BEAM $18.30
  • KAR $15.44
  • 52 Week High
  • BEAM $35.25
  • KAR $22.47
  • Technical
  • Relative Strength Index (RSI)
  • BEAM 30.05
  • KAR 36.18
  • Support Level
  • BEAM $18.30
  • KAR $18.87
  • Resistance Level
  • BEAM $22.97
  • KAR $19.51
  • Average True Range (ATR)
  • BEAM 1.66
  • KAR 0.60
  • MACD
  • BEAM -0.46
  • KAR -0.21
  • Stochastic Oscillator
  • BEAM 4.83
  • KAR 13.14

Stock Price Comparison Chart: BEAM vs KAR

BEAM
KAR
JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025April0102030405060708090100110120130140BEAM VS KAR

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company's portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing. The company's pipeline programs consist of BEAM-101, ESCAPE, BEAM-302, BEAM-301, and BEAM-201.

About KAR OPENLANE Inc.

Openlane Inc offers a digital marketplace for used vehicles. The services comprise financing, repossessions, repairs, transportation, warranty, and inventory services. It operates used-vehicle auctions and offers complete online services for all parties involved. The company has two operating segments which include Marketplace and Finance, of which it generates the majority of the revenue from the Marketplace segment.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use